Inecalcitol

Research use only, not for human use.

Inecalcitol is the growth inhibitor of human breast cancer cells. Inecalcitol is a unique vitamin D3 analog with Kd of 0.53 nM.

Inecalcitol is the growth inhibitor of human breast cancer cells. Inecalcitol is a unique vitamin D3 analog with Kd of 0.53 nM.(In Vitro):A xenograft model of LNCaP cells was developed in immunodeficient mice treated with inecalcitol. The tumors of the diluent-treated control mice increased in size but those in the inecalcitol treatment group did not grow.(In Vivo):Inecalcitol maximal tolerated dose (MTD) by intraperitoneal (i.p.) administration was 30 μg/mouse (1,300 μg/kg) three times per week, while we previously found that the MTD of 1,25(OH)(2) D(3) is 0.0625 μg/mouse; therefore, inecalcitol is 480 times less hypercalcemic than 1,25OH2 D3. Inecalcitol inhibits androgen-responsive prostate cancer growth in vivo.

TX-522; TX 522; TX522

Apoptosis

Apoptosis

HIPK2

——

——

163217-09-2

400.6

C26H40O3

>98% (HPLC)

——

C[C@H](CC#CC(C)(C)O)[C@H]1CC[C@@H]2\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1

——

(-20℃)

With Ice Pack

≥ 2 years